Drawing for NAXTRA

USPTO serial 79350342

NAXTRA

Reviewed by CopyMark Law Group

Reg. 7483797Status 700Registered
Filing date
Status date
Registration date
Aug 27, 2024
Examiner
COWARD, JEFFERY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NAXTRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marcus Martinez

Marcus Martinez Fox Swibel Levin & Carroll LLP200 W Madison St Suite 3000Chicago, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for chemical analyses for non-medical purposes; Diagnostic and molecular biology reagents for analyses of biological samples, cells, bacteria, virus, fungi, protozoa or worms other than for medical or veterinary purposes; reagents for scientific use; reagents for scientific purposes; reagents for diagnostic tests other than for medical or veterinary use; chemical reagents, other than for medical or veterinary use; Reagents and other preparations for scientific and research analysis, namely, chemical solutions for laboratory or medical research use, enzymes for scientific and research purposes, chemical preparations for scientific purposes, biological tissue cultures in the nature of human tissue, organoids of mammalian origin, human body fluids, animal tissue and animal body fluids, other than for medical or veterinary purposes, cultures of microorganisms other than for medical or veterinary use, plant tissue and nucleotides for use in science and research, none of the foregoing being for medical or veterinary use; Reagent kits for scientific and research use consisting of nucleotides, magnetic beads, reagents, enzymes, enzyme substrates, buffers, namely, chemical solutions for laboratory or medical research use, chemical preparations for scientific purposes, biological tissue cultures in the nature of human tissue, organoids of mammalian origin, human body fluids, animal tissue and animal body fluids, other than for medical or veterinary purposes, cultures of microorganisms other than for medical or veterinary use, plant tissue and enzymes all for use in science and research, not for medical or veterinary useACTIVE—
005Reagents for medical use; Medical diagnostic reagents and assays for testing body fluids, tissue or swab samples for pathogens in the form of bacteria, virus, fungi, protozoa or worms, and for genetic analyses of host cells for detection of predisposition or presence of genetic disorders or diseases; biological reagents for medical purposes; diagnostic reagents for medical purposes; pharmaceutical, medical and veterinary preparations, namely, kits comprised primarily of chemicals for sample preparation, namely, buffers, magnetic beads, enzymes obtained from body fluid, tissue and swab samples for medical purposes; chemical reagents for medical or veterinary use; clinical medical reagents; reagents for medical use, clinical medical diagnostic reagents, and medical diagnostic reagents for analysis, namely, chemical reagent solutions used in laboratory and medical testing for medical purposes and medical diagnostic purposes; enzymes, nucleotides, magnetic beads and buffers for medical diagnostic use, namely, chemical reagent solutions used in laboratory and medical testing for medical purposes; chemical reagents for medical purposes and biological analyses of tissue cultures in the form of human tissue, body fluids, organoids, animal tissue, and animal body fluids for medical purposes, cultures of pathogens in the form of bacteria, virus, fungi, protozoa or worms, and plant tissue all for medical and veterinary useACTIVE—
009Scientific apparatus and instruments, namely, automated liquid sample handling devices for scientific purposes used in laboratory settings in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, scientific diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, criminal investigations, food safety, metagenomics and geneticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 1, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 13, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 13, 2025FIMPFINAL DISPOSITION PROCESSED—
Nov 27, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 27, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 27, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 11, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 11, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 22, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 3, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 3, 2024XAECEXAMINER'S AMENDMENT ENTERED—
May 3, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 3, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
May 3, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 18, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 28, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 28, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 23, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 22, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2023RFNPREFUSAL PROCESSED BY IB—
May 16, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 15, 2023RFRRREFUSAL PROCESSED BY MPU—
Mar 28, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 27, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2023DOCKASSIGNED TO EXAMINER—
Oct 29, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 28, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 27, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 23, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance